Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases

FOSTER CITY, Calif. & BALLERUP, Denmark–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and LEO Pharma today announced a strategic partnership to accelerate the development and commercialization of LEO Pharma’s small molecule oral STAT6 (signal transducer and activator of transcription 6) programs for the potential treatment of patients with inflammatory diseases. STAT6 is the specific transcription factor required for IL-4 and IL-13 cytokine signaling, which are clinically validated tar
Read More

Immunis Closes $25 Million Series A-1 Financing Round

IRVINE, Calif.–(BUSINESS WIRE)– #ClinicalTrials–Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, has closed a $25 million Series A-1 financing round to fund two Phase 2 clinical trials. Follow-on investments from all major existing investors, notably, Remiges Ventures, Continuum Health Ventures and BOLD Capital Partners were joined by new investments from LifeSpan Vision Ventures and JLS Fund among others, including a leading global in
Read More

Experts highlight urgent need for US physician strike regulations

A new Perspective published in the New England Journal of Medicine led by researchers from the Harvard Pilgrim Health Care Institute calls for urgent regulatory reforms to address the rising trend of physician strikes in the United States. The piece provides a comprehensive analysis of the increasing frequency of physician strikes and offers a framework for U.S. policymakers to learn from international best practices.
Read More

Study suggests cognitive testing could improve Lewy body dementia diagnosis

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in Alzheimer’s & Dementia. Although DLB is the second most common neurodegenerative dementia following Alzheimer’s Disease, it is usually misdiagnosed, preventing affected people from accessing care better tailored to their prognosis.
Read More
Top